|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 1994; 23:393-400 © 1994 by the American College of Cardiology Foundation |
University of Alabama Medical Center, Birmingham 35294.
OBJECTIVES. This study was performed to assess the quality of life of patients with left ventricular dysfunction for up to 2 years after randomization to enalapril or placebo. BACKGROUND. Previous reports have documented that survival of patients with congestive heart failure can be extended by the angiotensin-converting enzyme inhibitor enalapril. However, it is unknown whether enalapril has a long-term favorable impact on the quality of life in patients with heart failure. METHODS. A brief quality of life questionnaire assessing the quality of life was administered at baseline and at 6 weeks, 1 year and 2 years of follow-up to patients randomized to placebo or enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). Participants had an ejection fraction < or = 0.35, no other serious illnesses and either symptomatic heart failure (treatment trial, n = 2,465) or asymptomatic left ventricular dysfunction (prevention trial, n = 2,560). RESULTS. Among the 14 scales of quality of life, better scores at one or more follow-up intervals were noted in 6 scales in the treatment trial and in 1 scale in the prevention trial among patients assigned to enalapril. Consistent superiority with enalapril at two consecutive follow-up intervals was noted in the treatment trial for social functioning and dyspnea but for no scale in the prevention trial. However, an average of 40% of quality of life responses were missing at 2 years of follow-up because of death or failure to complete the questionnaire. In the treatment trial, survivors with more severe heart failure were less likely to complete the questionnaire. CONCLUSIONS. Modest benefits in quality of life for > or = 1 year occurred when patients with left ventricular dysfunction and symptomatic heart failure were treated with enalapril. No apparent beneficial or adverse effect on quality of life was observed with enalapril in asymptomatic patients with left ventricular dysfunction.
This article has been cited by other articles:
|
|
 |
|
  J. G.F. Cleland, A. Charlesworth, J. Lubsen, K. Swedberg, W. J. Remme, L. Erhardt, A. Di Lenarda, M. Komajda, M. Metra, C. Torp-Pedersen, et al. A Comparison of the Effects of Carvedilol and Metoprolol on Well-Being, Morbidity, and Mortality (the "Patient Journey") in Patients With Heart Failure: A Report From the Carvedilol Or Metoprolol European Trial (COMET) J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1603 - 1611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Rodriguez-Artalejo, P. Guallar-Castillon, C. R. Pascual, C. M. Otero, A. O. Montes, A. N. Garcia, P. Conthe, M. O. Chiva, J. R. Banegas, and M. C. Herrera Health-Related Quality of Life as a Predictor of Hospital Readmission and Death Among Patients With Heart Failure Arch Intern Med, June 13, 2005; 165(11): 1274 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.D.R. Hobbs, J.E. Kenkre, A.K. Roalfe, R.C. Davis, R. Hare, and M.K. Davies Impact of heart failure and left ventricular systolic dysfunction on quality of life. A cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population Eur. Heart J., December 1, 2002; 23(23): 1867 - 1876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S D Hutcheon, N D Gillespie, I K Crombie, A D Struthers, and M E T McMurdo Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial Heart, October 1, 2002; 88(4): 373 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Riedinger, K. A. Dracup, M.-L. Brecht, and for the SOLVD Investigators Quality of Life in Women With Heart Failure, Normative Groups, and Patients With Other Chronic Conditions Am. J. Crit. Care., May 1, 2002; 11(3): 211 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Moinpour, L. C. Lovato, I. M. Thompson Jr, J. E. Ware Jr, P. A. Ganz, D. L. Patrick, S. A. Shumaker, G. W. Donaldson, A. Ryan, and C. A. Coltman Jr Profile of Men Randomized to the Prostate Cancer Prevention Trial: Baseline Health-Related Quality of Life, Urinary and Sexual Functioning, and Health Behaviors J. Clin. Oncol., May 9, 2000; 18(9): 1942 - 1953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Goff Jr, D. K. Pandey, F. A. Chan, C. Ortiz, and M. Z. Nichaman Congestive Heart Failure in the United States: Is There More Than Meets the I(CD Code)? The Corpus Christi Heart Project Arch Intern Med, January 24, 2000; 160(2): 197 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Irvine, A. Basinski, B. Baker, S. Jandciu, M. Paquette, J. Cairns, S. Connolly, R. Roberts, M. Gent, and P. Dorian Depression and Risk of Sudden Cardiac Death After Acute Myocardial Infarction: Testing for the Confounding Effects of Fatigue Psychosom Med, November 1, 1999; 61(6): 729 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. E. Pae Jr, J. M. Anderson, E. H. Blackstone, H. S. Boroevetz, A. Ciarkowski, J. G. Copeland III, M. R. Costanzo-Nordin, K. Daase, M. A. Dew, M. J. Domanski, et al. Bethesda conference: conference for the design of clinical trials to study circulatory support devices for chronic heart failure Ann. Thorac. Surg., October 1, 1998; 66(4): 1452 - 1465. [Full Text] [PDF]
|
|
|
|
|
|
P. Jaagosild, N. V. Dawson, C. Thomas, N. S. Wenger, J. Tsevat, W. A. Knaus, R. M. Califf, L. Goldman, H. Vidaillet, A. F. Connors Jr, et al. Outcomes of Acute Exacerbation of Severe Congestive Heart Failure: Quality of Life, Resource Use, and Survival Arch Intern Med, May 25, 1998; 158(10): 1081 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Eccles, N. Freemantle, and J. Mason North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure BMJ, May 2, 1998; 316(7141): 1369 - 1375. [Full Text]
|
|
|
|
 |
|
 M. W. Rich, V. Beckham, C. Wittenberg, C. L. Leven, K. E. Freedland, and R. M. Carney A Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart Failure N. Engl. J. Med., November 2, 1995; 333(18): 1190 - 1195. [Abstract] [Full Text] [PDF]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
